Literature DB >> 35462704

Cytotoxic Bioxanthracene and Macrocyclic Polyester from Endolichenic Fungus Talaromyces pinophilus: In-Vitro and In-Silico Analysis.

Chaitrali Shevkar1, Ashwini Armarkar1, Ramani Weerasinghe2, Kasun Maduranga2, Komal Pandey1, Santosh K Behera3, Kiran Kalia3, Priyani Paranagama2, Abhijeet S Kate1.   

Abstract

Lichens are used in folklore medicines across the globe for wound healing and to treat skin disorders and respiratory diseases. They are an intricate symbiosis between fungi and algae with the domination of fungal counterparts. Recent research studies pointed out that yeast is a third major partner in lichens. Endolichenic fungi (ELF) are also a part of this complex miniature ecosystem. The highly competitive environment of lichens compels ELF to produce toxic metabolites which are comparatively less explored for their chemical diversity and use. Here, we investigated 31 ELF isolated from 32 lichens found on mangrove plants at Puttalam Lagoon of Sri Lanka to find cytotoxic molecules by applying LC-UV-HRMS analysis and in vitro bioassays. The studies resulted in the identification of three potent cytotoxic molecules from endolichenic fungi Talaromyces pinophilus isolated from host lichen Porina tetracerae. The ethyl acetate extract of this fungus showed moderate cytotoxicity against the breast cancer cell line. Chemical characterization of ethyl acetate extract of T. pinophilus produced peniazaphilin B, 152G256α-1, and ES-242-3. The structures of these molecules were confirmed by NMR and MS data. We are reporting ES-242-3 for the first time from the genus Talaromyces and peniazaphilin B and 152G256α-1 from T. pinophilus. The isolated compounds were evaluated for their anticancer potential against breast, oral and cervical cancer cell lines. Compound 152G256α-1 showed potent cytotoxicity against oral cancer (CAL-27 cell line) with an IC50 value of 2.96 ± 0.17 µM while ES-242-3 showed the best activity against breast cancer (MCF-7 cell line) and cervical cancer (HeLa cell line) with IC50 value 14.08 ± 0.2 µM and 4.46 ± 0.05 µM respectively. An in-silico analysis was carried out to predict the mechanism of in-vitro activity, drug likeliness, and pharmacokinetic profile of the isolated compounds. The study confirms the potential of ELF T. pinophilus to produce diverse bioactive scaffolds and encourages the researchers to further explore the fungus and its metabolites with newer technologies to produce potent anticancer leads. Supplementary Information: The online version contains supplementary material available at 10.1007/s12088-021-00994-8. © Association of Microbiologists of India 2021.

Entities:  

Keywords:  152G256α-1; Anticancer; Cytotoxic; ES-242-3; Peniazaphilin B; Talaromyces pinophilus

Year:  2022        PMID: 35462704      PMCID: PMC8980127          DOI: 10.1007/s12088-021-00994-8

Source DB:  PubMed          Journal:  Indian J Microbiol        ISSN: 0046-8991            Impact factor:   2.461


  22 in total

1.  Bioxanthracenes from the insect pathogenic fungus Cordyceps pseudomilitaris BCC 1620. II. Structure elucidation.

Authors:  M Isaka; P Kongsaeree; Y Thebtaranonth
Journal:  J Antibiot (Tokyo)       Date:  2001-01       Impact factor: 2.649

Review 2.  Natural products as leads to anticancer drugs.

Authors:  M Gordaliza
Journal:  Clin Transl Oncol       Date:  2007-12       Impact factor: 3.405

3.  Assessment of the Alamar Blue assay for cellular growth and viability in vitro.

Authors:  G R Nakayama; M C Caton; M P Nova; Z Parandoosh
Journal:  J Immunol Methods       Date:  1997-05-26       Impact factor: 2.303

4.  Endolichenic Fungi: A Hidden Reservoir of Next Generation Biopharmaceuticals.

Authors:  Brahma N Singh; Dalip K Upreti; Vijai K Gupta; Xiao-Feng Dai; Yueming Jiang
Journal:  Trends Biotechnol       Date:  2017-03-28       Impact factor: 19.536

5.  Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019.

Authors:  David J Newman; Gordon M Cragg
Journal:  J Nat Prod       Date:  2020-03-12       Impact factor: 4.050

6.  Detection of serum/salivary exosomal Alix in patients with oral squamous cell carcinoma.

Authors:  Eiji Nakamichi; Hiroki Sakakura; Shinji Mii; Noriyuki Yamamoto; Hideharu Hibi; Masato Asai; Masahide Takahashi
Journal:  Oral Dis       Date:  2020-08-07       Impact factor: 3.511

7.  Peniazaphilin A, a new azaphilone derivative produced by Penicillium sp. CPCC 400786.

Authors:  Dewu Zhang; Jianyuan Zhao; Xinwei Wang; Lili Zhao; Hongyu Liu; Yuzhen Wei; Xuefu You; Shan Cen; Liyan Yu
Journal:  J Antibiot (Tokyo)       Date:  2018-07-05       Impact factor: 2.649

8.  Cytotoxic activity of caffeic acid and gallic acid against MCF-7 human breast cancer cells: An in silico and in vitro study.

Authors:  Hasan Rezaei-Seresht; Hamid Cheshomi; Farahnaz Falanji; Fatemeh Movahedi-Motlagh; Maryam Hashemian; Erfan Mireskandari
Journal:  Avicenna J Phytomed       Date:  2019 Nov-Dec

9.  The universal protein resource (UniProt).

Authors: 
Journal:  Nucleic Acids Res       Date:  2007-11-27       Impact factor: 16.971

Review 10.  Transdermal buprenorphine and fentanyl patches in cancer pain: a network systematic review.

Authors:  Jin Seok Ahn; Johnson Lin; Setsuro Ogawa; Chen Yuan; Tony O'Brien; Brian Hc Le; Andrea M Bothwell; Hanlim Moon; Yacine Hadjiat; Abhijith Ganapathi
Journal:  J Pain Res       Date:  2017-08-18       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.